AstraZeneca said on Tuesday that it is working with Oracle to use AI ​and real-world data to identify eligible ‌patients for clinical trials and monitor safety signals, among other measures, as the drugmaker looks to ​improve clinical research.

Log in or sign up to comment.

No comments yet.

← Back to stories

Create FREE account

or login to continue

Signup with GoogleSignup with GitHubSignup with BlueskySignup with Blacksky
Sign up with email

Already have an account? Log in